Table 1 Baseline characteristics by treatment arm
Azithromycin (N = 230) | Placebo (N = 220) | |
|---|---|---|
Age, months, median (IQR) | 26 (15 to 39) | 26 (17 to 38) |
Female sex, N (%) | 122 (53.1%) | 106 (48.4%) |
Currently breastfeeding, N (%) | 93 (40.4%) | 78 (35.6%) |
Mother’s age, years, median (IQR) | 26.5 (23 to 32) | 27 (23 to 33) |
Malaria parasitaemia, N (%) | 42 (18.3%) | 36 (16.4%) |
Parasite density, parasites/µl, median (IQR) | 960 (84 to 15,900) | 1160 (80 to 9940) |
Gametocytaemia, N (%) | 37 (16.2%) | 26 (11.9%) |
Positive RDT for malariaa | 14 (6.1%) | 8 (3.6%) |